Publications & Presentations

The information in our publications and presentations should be considered accurate only as of the date of the publications or presentations. We disclaim any obligation to supplement or update the information in these publications and presentations.

To learn more about our innovative technology:

Publications Presentations

Exploratory Efficacy of INP104 by Migraine Attack Severity and Time of Dosing: Results From the Phase 3 STOP 301 Study

Presented at PAINWeek Conference, September 7-11, 2021, Las Vegas, NV, USA Authors: Brian D. Loftus, MD, Michelle Murphy, PhD, Christopher J. Fitzpatrick, PhD, Sutapa Ray, Stephen B. Shrewsbury, MB ChB, Sheena K. Aurora, MD Purpose: It is increasingly recognized that…

Improvements in Disability and the Interictal Period with INP104: Results from the Phase 3 STOP 301 Study

Presented at PAINWeek Conference, September 7-11, 2021, Las Vegas, NV, USA Authors: Dawn C. Buse, PhD, Cynthia E. Armand, MD, Robert Vann, PhD, Sutapa Ray, Stephen B. Shrewsbury, MB ChB, Sheena K. Aurora, MD Purpose: Migraine is a highly prevalent…

Patient Acceptability of INP104 Aligns With the Unmet Needs Identified in the I-BEAM Survey

Presented at PAINWeek Conference, September 7-11, 2021, Las Vegas, NV, USA Authors: Jessica Ailani, MD, Kate Kennedy, ARNP-BC, TinaMarie Lieu, PhD, John Hoekman, PhD, Maria Jeleva, PhD, Sutapa Ray, Stephen B. Shrewsbury, MB ChB, Sheena K. Aurora, MD Purpose: Migraine…

1 2 3